×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Investors Who Bought Outlook Therapeutics (NASDAQ:OTLK) Shares Three Years Ago Are Now Down 98%
Yahoo Movies Canada
As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like...
11 hours ago
Research Analysts Offer Predictions for Outlook Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:OTLK)
Defense World
Read Research Analysts Offer Predictions for Outlook Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:OTLK) at Defense World.
1 day ago
Outlook Therapeutics, Inc. (NASDAQ:OTLK) to Post FY2024 Earnings of ($11.82) Per Share, Chardan Capital Forecasts
MarketBeat
Outlook Therapeutics, Inc. (NASDAQ:OTLK - Free Report) - Equities researchers at Chardan Capital reduced their FY2024 earnings estimates for...
2 days ago
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a ...
GlobeNewswire
UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP)...
1 week ago
US FDA declines to approve Outlook Therapeutics' eye disease drug
Reuters
Outlook Therapeutics said on Wednesday the U.S. Food and Drug Administration declined to approve its experimental eye disease drug,...
8 months ago
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
Yahoo Finance
Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days...
2 months ago
Outlook Therapeutics, Inc. (NASDAQ:OTLK) to Post Q1 2025 Earnings of ($1.00) Per Share, HC Wainwright Forecasts
Defense World
Read Outlook Therapeutics, Inc. (NASDAQ:OTLK) to Post Q1 2025 Earnings of ($1.00) Per Share, HC Wainwright Forecasts at Defense World.
5 days ago
Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
GlobeNewswire
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company...
2 months ago
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
Yahoo Finance
Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for...
1 week ago
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host ...
GlobeNewswire
ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the...
2 weeks ago